Gene Therapy of Malignant Solid Tumors by Targeting erbB2 Receptors and by Activating T Cells-Reference-Cited by-同舟云学术

Gene Therapy of Malignant Solid Tumors by Targeting erbB2 Receptors and by Activating T Cells

Published:2012-12 Issue:10 Volume:27 Page:711-718
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Hu Wang-Xiong¹,Chen He-Ping²,Yu Kang³,Shen Lu-Xi⁴,Wang Chao-Yan¹,Su Shi-Zhen¹,Sui Wen-Jun¹,Shan Da-Ming³,Li Hong-Zhi¹

Affiliation:

1. Zhejiang Provincial Key Laboratory of Medical Genetics, Wenzhou Medical College, Wenzhou, People's Republic of China.

2. Dental School, University of Texas Health Science Center at San Antonio, San Antonio, Texas.

3. Wenzhou Medical College, The First Affiliated Hospital, Wenzhou, People's Republic of China.

4. Capital Medical University, Xuanwu Hospital, Beijing, People's Republic of China.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2012.1246

Reference58 articles.

1. A Trimeric Anti-HER2/neuScFv and Tumor Necrosis Factor-α Fusion Protein Induces HER2/neuSignaling and Facilitates Repair of Injured Epithelia

2. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies

3. ERBB2 oncogene in human breast cancer and its clinical significance

4. Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer

5. A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Cancer Potential of Transiently Transfected HER2-Specific Human Mixed CAR-T and NK Cell Populations in Experimental Models: Initial Studies on Fucosylated Chondroitin Sulfate Usage for Safer Treatment;Biomedicines;2023-09-18

2. Trastuzumab‐based near‐infrared photoimmunotherapy in xenograft mouse of breast cancer;Cancer Medicine;2022-10-18

3. Chimeric antigen receptor T-cell therapy for breast cancer;Future Oncology;2021-08

4. Clinical development of CAR T cell therapy in China: 2020 update;Cellular & Molecular Immunology;2020-09-30

5. Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells;International Journal of Molecular Sciences;2017-09-08